Idowu MO - Search Results

1

Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells.

Madan E, Palma AM, Vudatha V, Kumar A, Bhoopathi P, Wilhelm J, Bernas T, Martin PC, Bilolikar G, Gogna A, Peixoto ML, Dreier I, Araujo TF, Garre E, Gustafsson A, Dorayappan KDP, Mamidi N, Sun Z, Yekelchyk M, Accardi D, Olsen AL, Lin L, Titelman AA, Bianchi M, Jessmon P, Farid EA, Pradhan AK, Neufeld L, Yeini E, Maji S, Pelham CJ, Kim H, Oh D, Rolfsnes HO, Marques RC, Lu A, Nagane M, Chaudhary S, Gupta K, Gogna KC, Bigio A, Bhoopathi K, Mannangatti P, Achary KG, Akhtar J, Belião S, Das S, Correia I, da Silva CL, Fialho AM, Poellmann MJ, Javius-Jones K, Hawkridge AM, Pal S, Shree KS, Rakha EA, Khurana S, Xiao G, Zhang D, Rijal A, Lyons C, Grossman SR, Turner DP, Pillappa R, Prakash K, Gupta G, Robinson GLWG, Koblinski J, Wang H, Singh G, Singh S, Rayamajhi S, Bacolod MD, Richards H, Sayeed S, Klein KP, Chelmow D, Satchi-Fainaro R, Selvendiran K, Connolly D, Thorsen FA, Bjerkvig R, Nephew KP, Idowu MO, Kühnel MP, Moskaluk C, Hong S, Redmond WL, Landberg G, Lopez-Beltran A, Poklepovic AS, Sanyal A, Fisher PB, Church GM, Menon U, Drapkin R, Godwin AK, Luo Y, Ackermann M, Tzankov A, Mertz KD, Jonigk D, Tsung A, Sidransky D, Trevino J, Saavedra AP, Winn R, Won KJ, Moreno E, Gogna … See abstract for full author list ➔ Madan E, et al. Among authors: idowu mo. Nat Biotechnol. 2024 Dec 9. doi: 10.1038/s41587-024-02453-3. Online ahead of print. Nat Biotechnol. 2024. PMID: 39653752

2

Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.

Pradhan AK, Maji S, Bhoopathi P, Talukdar S, Mannangatti P, Guo C, Wang XY, Cartagena LC, Idowu M, Landry JW, Sarkar D, Emdad L, Cavenee WK, Das SK, Fisher PB. Pradhan AK, et al. Proc Natl Acad Sci U S A. 2021 May 25;118(21):e2103180118. doi: 10.1073/pnas.2103180118. Proc Natl Acad Sci U S A. 2021. PMID: 34016751 Free PMC article.

3

Preferential human epidermal growth factor receptor 2 expression in myometrial and lymphovascular invasion of a uterine carcinosarcoma: A case report.

Gillam J, Pillappa R, Idowu M, Boardman C, Sullivan SA, Sayeed S. Gillam J, et al. SAGE Open Med Case Rep. 2022 Mar 5;10:2050313X221081361. doi: 10.1177/2050313X221081361. eCollection 2022. SAGE Open Med Case Rep. 2022. PMID: 35273799 Free PMC article.

4

Metastatic Uterine Leiomyosarcoma presenting as small bowel intussusception at two independent visits.

Sparkman BK, Pearce J, Klein K, Idowu M, Askari K, Fernandez LJ, Trevino JG, Sullivan SA, Miller DT, Randall LM. Sparkman BK, et al. Gynecol Oncol Rep. 2023 Nov 22;51:101306. doi: 10.1016/j.gore.2023.101306. eCollection 2024 Feb. Gynecol Oncol Rep. 2023. PMID: 38192357 Free PMC article.

5

An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition.

Chawla AT, Cororaton AD, Idowu MO, Damle PK, Szomju B, Ellis KC, Patel BB, Grossman SR. Chawla AT, et al. Among authors: idowu mo. Oncotarget. 2018 Aug 21;9(65):32408-32418. doi: 10.18632/oncotarget.25784. eCollection 2018 Aug 21. Oncotarget. 2018. PMID: 30197752 Free PMC article.

6

Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization.

Cartagena LC, McGuire K, Zot P, Pillappa R, Idowu M, Robila V. Cartagena LC, et al. Clin Breast Cancer. 2021 Oct;21(5):e594-e601. doi: 10.1016/j.clbc.2021.03.003. Epub 2021 Mar 8. Clin Breast Cancer. 2021. PMID: 33814286

7

CtBP-a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma.

Chawla AT, Chougoni KK, Joshi PJ, Cororaton AD, Memari P, Stansfield JC, Park H, Seth R, Szomju B, Sima AP, Idowu MO, Ellis KC, Grossman SR. Chawla AT, et al. Among authors: idowu mo. Oncogenesis. 2019 Oct 4;8(10):55. doi: 10.1038/s41389-019-0163-x. Oncogenesis. 2019. PMID: 31586042 Free PMC article.

8

Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma.

Chougoni KK, Park H, Damle PK, Mason T, Cheng B, Dcona MM, Szomju B, Dozmorov MG, Idowu MO, Grossman SR. Chougoni KK, et al. Among authors: idowu mo. Oncogenesis. 2023 Nov 10;12(1):53. doi: 10.1038/s41389-023-00498-8. Oncogenesis. 2023. PMID: 37949862 Free PMC article.

9

Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets.

Aqbi HF, Coleman C, Zarei M, Manjili SH, Graham L, Koblinski J, Guo C, Xie Y, Guruli G, Bear HD, Idowu MO, Habibi M, Wang XY, Manjili MH. Aqbi HF, et al. Among authors: idowu mo. Breast Cancer Res. 2020 Oct 28;22(1):116. doi: 10.1186/s13058-020-01357-9. Breast Cancer Res. 2020. PMID: 33115528 Free PMC article.

10

Syndecan-1 facilitates breast cancer metastasis to the brain.

Sayyad MR, Puchalapalli M, Vergara NG, Wangensteen SM, Moore M, Mu L, Edwards C, Anderson A, Kall S, Sullivan M, Dozmorov M, Singh J, Idowu MO, Koblinski JE. Sayyad MR, et al. Among authors: idowu mo. Breast Cancer Res Treat. 2019 Nov;178(1):35-49. doi: 10.1007/s10549-019-05347-0. Epub 2019 Jul 20. Breast Cancer Res Treat. 2019. PMID: 31327090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters